These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12927392)

  • 1. The effects of organic salts on the cyclodextrin solubilization of drugs.
    Loftsson T; Matthíasson K; Másson M
    Int J Pharm; 2003 Aug; 262(1-2):101-7. PubMed ID: 12927392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
    Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
    Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
    Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrins as solubilizers: formation of complex aggregates.
    Jansook P; Kurkov SV; Loftsson T
    J Pharm Sci; 2010 Feb; 99(2):719-29. PubMed ID: 19670293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P; Loftsson T
    Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of 19F-NMR as a tool for investigation of drug-cyclodextrin complexes.
    Másson M; Sigurjónsdóttir JF; Jónsdóttir S; Loftsson T
    Drug Dev Ind Pharm; 2003 Jan; 29(1):107-12. PubMed ID: 12602498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
    Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-association and cyclodextrin solubilization of drugs.
    Loftsson T; Magnúsdóttir A; Másson M; Sigurjónsdóttir JF
    J Pharm Sci; 2002 Nov; 91(11):2307-16. PubMed ID: 12379916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydroxypropyl-beta-cyclodextrin on hydrocortisone dissolution from films intended for ocular drug delivery.
    Bećirević-Laćan M; Filipović-Grcić J
    Pharmazie; 2000 Jul; 55(7):518-20. PubMed ID: 10944780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
    He Y; Li P; Yalkowsky SH
    Int J Pharm; 2003 Oct; 264(1-2):25-34. PubMed ID: 12972333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Filipović-Grcić J; Voinovich D; Moneghini M; Becirevic-Lacan M; Magarotto L; Jalsenjak I
    Eur J Pharm Sci; 2000 Feb; 9(4):373-9. PubMed ID: 10664477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrin solubilization of ETH-615, a zwitterionic drug.
    Loftsson T; Petersen DS
    Drug Dev Ind Pharm; 1998 Apr; 24(4):365-70. PubMed ID: 9876597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Tinwalla AY; Hoesterey BL; Xiang TX; Lim K; Anderson BD
    Pharm Res; 1993 Aug; 10(8):1136-43. PubMed ID: 8415398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
    Cavalli R; Peira E; Caputo O; Gasco MR
    Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol sustained release from high affinity cyclodextrin hydrogels.
    Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Rodriguez-Perez A; Concheiro A; Torres-Labandeira JJ
    Eur J Pharm Biopharm; 2007 Apr; 66(1):55-62. PubMed ID: 17081737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
    Chang RK; Shojaei AH
    Drug Dev Ind Pharm; 2004 Mar; 30(3):297-302. PubMed ID: 15109029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
    Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
    J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.